Crossmark

[11C]JNJ54173717, a novel P2X7 receptor radioligand as marker for neuroinflammation: human biodistribution, dosimetry, brain kinetic modelling and quantification of brain P2X7 receptors in patients with Parkinson’s disease and healthy volunteers

Crossref DOI link: https://doi.org/10.1007/s00259-019-04369-6

Published Online: 2019-06-26

Published Print: 2019-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Van Weehaeghe, Donatienne https://orcid.org/0000-0001-6646-106X
Koole, Michel

Schmidt, Mark E.

Deman, Stephanie

Jacobs, Andreas H.

Souche, Erika

Serdons, Kim

Sunaert, Stefan

Bormans, Guy

Vandenberghe, Wim

Van Laere, Koen
Funding

Funding for this research was provided by:

Michael J. Fox Foundation for Parkinson’s Research (12062)

FP7 Ideas: European Research Council (Inmind)
License Information

Text and Data Mining valid from 2019-06-26

Version of Record valid from 2019-06-26
More Information

Article History

Received: 24 January 2019

Accepted: 23 May 2019

First Online: 26 June 2019

Compliance with ethical standards

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the principles of the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards.

: Written informed consent was obtained from all individual participants prior to their inclusion in the study.

: None.

Document is current

Any future updates will be listed below